Allenex AB Strengthens Presence on the European Transplantations Market
4/27/2012 10:14:02 AM
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: As a part of Allenex (STO:ALNX) focus to build a global transplantation technology company with a strong sales and support organization the company now choose to sell directly to end customers in Holland and Belgium. The cooperation with the present distributor, Genome Products BV is terminated and Allenex will sell through its own sales organization, Olerup GmbH, starting May 1st, 2012.
comments powered by